U.S. flag

An official website of the United States government

GTR Home > Tests > CYP2D6 genotyping

Overview

Test name

Help

CYP2D6 genotyping

Purpose of the test

Help

This is a clinical test intended for Help: Drug Response

Condition

Help

Click Indication tab for more information.

How to order

Help

Order URL Help: http://www.alphagenomix.com

Methodology

Help
Molecular Genetics
TTargeted variant analysis
RT-qPCR
  • ABI QuantStudio 12K plus AccuFil system
  • TaqMan OpenArray, TaqMan Copy Number Assays

Summary of what is tested

Click Methodology tab for more information.

Clinical utility

Help

Not provided

Clinical validity

Help

Not provided

Practice guidelines

  • DailyMed Drug Label, 2020
    DailyMed Drug Label, DESIPRAMINE HYDROCHLORIDE tablet, 2020
  • DailyMed Drug Label, 2019
    DailyMed Drug Label, desipramine, 2019
  • CPIC, 2017
    Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
  • CPIC, 2013
    Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants. (See 2016 Update)

Consumer resources

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.